Clint Sever - 22 Nov 2022 Form 4 Insider Report for Cue Health Inc.

Role
Chief Product Officer
Signature
/s/ Erica Palsis, Attorney-in-Fact for Clint Sever
Issuer symbol
N/A
Transactions as of
22 Nov 2022
Net transactions value
-$134,005
Form type
4
Filing time
25 Nov 2022, 17:07:13 UTC
Previous filing
10 Nov 2022
Next filing
01 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HLTH Common Stock Options Exercise $3,818 +19,089 +0.48% $0.2000 3,969,369 22 Nov 2022 Direct F1
transaction HLTH Common Stock Sale $48,868 -19,089 -0.48% $2.56* 3,950,280 22 Nov 2022 Direct F1, F2
transaction HLTH Common Stock Options Exercise $3,818 +19,089 +0.48% $0.2000 3,969,369 23 Nov 2022 Direct F1
transaction HLTH Common Stock Sale $49,250 -19,089 -0.48% $2.58* 3,950,280 23 Nov 2022 Direct F1, F3
transaction HLTH Common Stock Options Exercise $3,818 +19,089 +0.48% $0.2000 3,969,369 25 Nov 2022 Direct F1
transaction HLTH Common Stock Sale $47,341 -19,089 -0.48% $2.48* 3,950,280 25 Nov 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLTH Employee Stock Option (right to buy) Options Exercise $0 -19,089 -12% $0.000000 140,983 22 Nov 2022 Common Stock 19,089 $0.2000 Direct F1, F5
transaction HLTH Employee Stock Option (right to buy) Options Exercise $0 -19,089 -14% $0.000000 121,894 23 Nov 2022 Common Stock 19,089 $0.2000 Direct F1, F5
transaction HLTH Employee Stock Option (right to buy) Options Exercise $0 -19,089 -16% $0.000000 102,805 25 Nov 2022 Common Stock 19,089 $0.2000 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were automatically effected pursuant to a rule 10b5-1 trading plan adopted on June 6, 2022 and established by the reporting person for the purpose of an orderly sale of shares related to the exercises of options scheduled to expire on December 31, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.49 to $2.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.63, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.42 to $2.53, inclusive.
F5 Shares subject to the option are fully vested and immediately exercisable.